PHARMACOTHERAPY OF BULIMIA-NERVOSA AND BINGE-EATING DISORDER - LONGER-TERM OUTCOMES

Authors
Citation
Ws. Agras, PHARMACOTHERAPY OF BULIMIA-NERVOSA AND BINGE-EATING DISORDER - LONGER-TERM OUTCOMES, Psychopharmacology bulletin, 33(3), 1997, pp. 433-436
Citations number
26
Categorie Soggetti
Psychiatry,Psychiatry,"Clinical Neurology","Pharmacology & Pharmacy
Journal title
ISSN journal
00485764
Volume
33
Issue
3
Year of publication
1997
Pages
433 - 436
Database
ISI
SICI code
0048-5764(1997)33:3<433:POBABD>2.0.ZU;2-C
Abstract
The longer-term effects of antidepressant medication, with and without the addition of psychotherapy, for the treatment of bulimia nervosa a nd binge eating disorder are reviewed. The use of a single antidepress ant agent results in recovery of about 25 percent of patients entering treatment; continued treatment is accompanied by relapse in about one -third of these patients. Substituting one or more antidepressants for the initial agent in patients who fail to improve or cannot tolerate side effects improves long-term maintenance. Adding cognitive-behavior al therapy (CBT) may prevent relapse once medication is discontinued, and the combination of CBT and antidepressant treatment is more effect ive than a single medication. There is also evidence that antidepressa nt treatment combined with CBT is more effective than placebo plus CBT . The problem of how to sequence medication and CBT has not been resol ved, although a recent study demonstrating that pharmacotherapy is mor e cost-effective than CBT suggests that treatment might begin with med ication.